VTX958 for the Treatment of Moderately to Severely Active Crohn's Disease
Public ClinicalTrials.gov record NCT05688852. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VTX958 in Participants With Moderately to Severely Active Crohn's Disease
Study identification
- NCT ID
- NCT05688852
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Ventyx Biosciences, Inc
- Industry
- Enrollment
- 107 participants
Conditions and interventions
Conditions
Interventions
- VTX958 Drug
- VTX958 Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 24, 2023
- Primary completion
- Jun 26, 2024
- Completion
- Dec 19, 2024
- Last update posted
- Jul 2, 2025
2023 – 2024
United States locations
- U.S. sites
- 26
- U.S. states
- 15
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Site # 840105 | Garden Grove | California | 92845 | — |
| Local Site # 840109 | Lancaster | California | 93534 | — |
| Local Site # 840124 | Kissimmee | Florida | 34744 | — |
| Local Site # 840104 | Miami | Florida | 33165 | — |
| Local Site # 840108 | Orlando | Florida | 32806 | — |
| Local Site # 840125 | Orlando | Florida | 32825 | — |
| Local Site # 840112 | Atlanta | Georgia | 30342 | — |
| Local Site # 840115 | Glenview | Illinois | 60026 | — |
| Local Site # 840107 | Gurnee | Illinois | 60031 | — |
| Local Site # 840119 | New Albany | Indiana | 47150 | — |
| Local Site # 840127 | Louisville | Kentucky | 40218 | — |
| Local Site # 840113 | Shreveport | Louisiana | 71105 | — |
| Local Site # 840117 | Chevy Chase | Maryland | 20815 | — |
| Local Site # 840118 | Rockville | Maryland | 20850 | — |
| Local Site # 840116 | Liberty | Missouri | 64068 | — |
| Local Site # 840121 | Winston-Salem | North Carolina | 27103 | — |
| Local Site # 840122 | Columbus | Ohio | 43202 | — |
| Local Site # 840106 | Oklahoma City | Oklahoma | 73102 | — |
| Local Site # 840123 | Myrtle Beach | South Carolina | 29572 | — |
| Local Site # 840111 | Garland | Texas | 75044 | — |
| Local Site # 840103 | Katy | Texas | 77484 | — |
| Local Site # 840110 | Lubbock | Texas | 79410 | — |
| Local Site # 840114 | Lubbock | Texas | 79424 | — |
| Local Site # 840102 | Southlake | Texas | 76092 | — |
| Local Site # 840101 | Tyler | Texas | 75701 | — |
| Local Site # 840126 | West Jordan | Utah | 84088 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 79 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05688852, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 2, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05688852 live on ClinicalTrials.gov.